+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial



Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial



European Journal of Pediatrics 174(2): 177-181



Intermittent phototherapy with "12 h on and then 12 h off" schedule in comparison with continuous phototherapy for neonatal hyperbilirubinemia may save costs and decrease anxiety of parents. In this non-inferiority-randomized controlled trial, healthy late preterm (>34 weeks) and term neonates with neonatal hyperbilirubinemia under phototherapy for 8 h and total serum bilirubin (TSB) < 18 mg/dL were randomized either into intermittent (IPT) or continuous (CPT) group. Infants in IPT group received 12 h on and 12 h off cycles of phototherapy. In both arms, phototherapy was continued until TSB < 13 mg/dL. Primary outcome was rate of fall of bilirubin. Seventy-five infants (IPT n = 36 vs. CPT n = 39) were enrolled in the study. The rate of fall of bilirubin was significantly higher with "IPT" phototherapy (p = 0.002). In term and late preterm infants with non-hemolytic moderate hyperbilirubinemia, intermittent phototherapy with 12 h on and 12 h off cycles is as efficacious as continuous phototherapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053918396

Download citation: RISBibTeXText

PMID: 25005717

DOI: 10.1007/s00431-014-2373-8


Related references

Controlled trial comparing agar, intermittent phototherapy, and continuous phototherapy for reducing neonatal hyperbilirubinemia. Journal of Pediatrics 82(1): 73-76, 1973

Randomized controlled trial of compact fluorescent lamp versus standard phototherapy for the treatment of neonatal hyperbilirubinemia. Indian Pediatrics 43(7): 583-590, 2006

Broad-spectrum light versus blue light for phototherapy in neonatal hyperbilirubinemia: a randomized controlled trial. American Journal of Perinatology 32(8): 779-784, 2015

Light Emitting Diode (LED) Phototherapy versus Conventional Phototherapy in Neonatal Hyperbilirubinemia: A Single Blinded Randomized Control Trial from Coastal India. Biomed Research International 2019: 6274719, 2019

Green light-emitting diode phototherapy for neonatal hyperbilirubinemia: Randomized controlled trial. Pediatrics International 61(5): 465-470, 2019

Randomized, controlled trial of phototherapy for neonatal hyperbilirubinemia. Executive summary. Pediatrics 75(2 Pt 2): 385-386, 1985

Controlled study on various hematological and blood chemistry changes during continuous and intermittent phototherapy for the prevention of physiologic hyperbilirubinemia in low weight newborn infants. Minerva Pediatrica 29(29): 1759-1766, 1977

Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial. Plos one 12(5): E0175922, 2017

Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial. Pediatrics 143(2):, 2019

Randomized, controlled trial of phototherapy for neonatal hyperbilirubinemia. Development, design, and sample composition. Pediatrics 75(2 Pt 2): 387-392, 1985

BiliBlanket phototherapy system versus conventional phototherapy: A randomized controlled trial in preterm infants. Journal of Paediatrics and Child Health 31(1): 11-13, 1995

Continuous and intermittent phototherapy of neonatal hyperbilirubinemia. Ceskoslovenska Pediatrie 34(10): 572-576, 1979

Continuous or intermittent phototherapy of neonatal hyperbilirubinemia. Ugeskrift for Laeger 142(28): 1810-1812, 1980

Randomized controlled trial of induction at 38 weeks versus 40 weeks gestation on maternal and infant outcomes in women with insulin-controlled gestational diabetes. Wiener Klinische Wochenschrift 129(17-18): 618-624, 2017

Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial. Pediatrics 102(5): 1153-1160, 1998